BibbInstruments AB BIBB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
BibbInstruments AB develops disposable biopsy instrumentation under the brand EndoDrill for early detection of cancer tumors, especially in deep-tissue tumors. The product portfolio includes six disposable instruments based on the patented EndoDrill technology and a novel biopsy method still under development. The instruments will be used for tissue sampling (biopsy) of the most common types of cancer, for example; lung, breast, colorectal, prostate and stomach cancer.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 3
- Website
- http://www.bibbinstruments.com
Valuation
Metric
|
BIBB
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 3.54 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
BIBB
|
---|---|
Quick Ratio | 7.02 |
Current Ratio | 7.02 |
Interest Coverage | — |
Quick Ratio
BIBB
Profitability
Metric
|
BIBB
|
---|---|
Return on Assets (Normalized) | −28.94% |
Return on Equity (Normalized) | −30.82% |
Return on Invested Capital (Normalized) | −31.08% |
Return on Assets
BIBB
Medical Devices Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ABT
| Abbott Laboratories | Lgxvydqt | Nfrdl | $184.2 Bil | |
SYK
| Stryker Corp | Tkzxqdnj | Pmfs | $125.1 Bil | |
MDT
| Medtronic PLC | Jtdhlmq | Hcybgn | $108.5 Bil | |
BSX
| Boston Scientific Corp | Pmvqbzz | Ymzvn | $107.1 Bil | |
EW
| Edwards Lifesciences Corp | Whrfbzsxp | Dmqfzz | $51.4 Bil | |
DXCM
| DexCom Inc | Dwzxcsrlp | Spnqc | $50.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Qqlwprjnp | Xghyj | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Flfpxxznz | Kfwmtny | $24.4 Bil | |
ALGN
| Align Technology Inc | Btfcnkc | Gcjvv | $21.7 Bil | |
PODD
| Insulet Corp | Gzqnxzqvlg | Tszqx | $12.2 Bil |